These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31422940)

  • 1. Ubiquitination and SUMOylation of Amyloid and Amyloid-like Proteins in Health and Disease.
    Ford L; Fioriti L; Kandel ER
    Curr Issues Mol Biol; 2020; 35():195-230. PubMed ID: 31422940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Abundance and Subverted Functions of Proteins in Prion-Like Diseases: Gained Functions Fascinate but Lost Functions Affect Aetiology.
    Allison WT; DuVal MG; Nguyen-Phuoc K; Leighton PLA
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.
    Luo HB; Xia YY; Shu XJ; Liu ZC; Feng Y; Liu XH; Yu G; Yin G; Xiong YS; Zeng K; Jiang J; Ye K; Wang XC; Wang JZ
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16586-91. PubMed ID: 25378699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the Role of Aberrant Protein Post-Translational Modification in the Pathology of Neurodegeneration.
    Shafi S; Singh A; Gupta P; Chawla PA; Fayaz F; Sharma A; Pottoo FH
    CNS Neurol Disord Drug Targets; 2021; 20(1):54-67. PubMed ID: 32885763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Involvement of Post-Translational Modifications in Alzheimer's Disease.
    Marcelli S; Corbo M; Iannuzzi F; Negri L; Blandini F; Nistico R; Feligioni M
    Curr Alzheimer Res; 2018 Feb; 15(4):313-335. PubMed ID: 28474569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of SOD1 regulation by post-translational modifications.
    Banks CJ; Andersen JL
    Redox Biol; 2019 Sep; 26():101270. PubMed ID: 31344643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein SUMOylation, an emerging pathway in amyotrophic lateral sclerosis.
    Dangoumau A; Veyrat-Durebex C; Blasco H; Praline J; Corcia P; Andres CR; Vourc'h P
    Int J Neurosci; 2013 Jun; 123(6):366-74. PubMed ID: 23289752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
    Marrero-Winkens C; Sankaran C; Schätzl HM
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain.
    Thomas SN; Yang AJ
    Methods Mol Biol; 2017; 1523():161-177. PubMed ID: 27975250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between Ubiquitination and Other Post-translational Protein Modifications in Plant Immunity.
    Zhang Y; Zeng L
    Plant Commun; 2020 Jul; 1(4):100041. PubMed ID: 33367245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aromatic and aliphatic residues of the disordered region of TDP-43 are on a fast track for self-assembly.
    Laurents DV; Stuani C; Pantoja-Uceda D; Buratti E; Mompeán M
    Biochem Biophys Res Commun; 2021 Nov; 578():110-114. PubMed ID: 34560580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biophysical and Spectroscopic Methods for Monitoring Protein Misfolding and Amyloid Aggregation.
    Cristóvão JS; Henriques BJ; Gomes CM
    Methods Mol Biol; 2019; 1873():3-18. PubMed ID: 30341600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeast Prions Compared to Functional Prions and Amyloids.
    Wickner RB; Edskes HK; Son M; Bezsonov EE; DeWilde M; Ducatez M
    J Mol Biol; 2018 Oct; 430(20):3707-3719. PubMed ID: 29698650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why are Functional Amyloids Non-Toxic in Humans?
    Jackson MP; Hewitt EW
    Biomolecules; 2017 Sep; 7(4):. PubMed ID: 28937655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prions and Non-infectious Amyloids of Mammals - Similarities and Differences.
    Galkin AP; Velizhanina ME; Sopova YV; Shenfeld AA; Zadorsky SP
    Biochemistry (Mosc); 2018 Oct; 83(10):1184-1195. PubMed ID: 30472956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.
    Chen Z; Lu W
    Int J Mol Sci; 2015 Feb; 16(3):4560-80. PubMed ID: 25734985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions.
    Shrivastava AN; Aperia A; Melki R; Triller A
    Neuron; 2017 Jul; 95(1):33-50. PubMed ID: 28683268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases.
    Díaz-Nido J; Wandosell F; Avila J
    Peptides; 2002 Jul; 23(7):1323-32. PubMed ID: 12128089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitration in neurodegeneration: deciphering the "Hows" "nYs".
    Reynolds MR; Berry RW; Binder LI
    Biochemistry; 2007 Jun; 46(25):7325-36. PubMed ID: 17542619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO and Alzheimer's disease.
    Lee L; Sakurai M; Matsuzaki S; Arancio O; Fraser P
    Neuromolecular Med; 2013 Dec; 15(4):720-36. PubMed ID: 23979993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.